Correction to: “The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study” - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Erratum: "Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Patients with Type 2 Diabetes - Insights from a Real-World Analysis

  • August 26, 2025

Share

  • 1

    The article addresses corrections to authorship and funding in a previous publication.

  • 2

    Benaya Rozen-Zvi's name was corrected to include a hyphen in the authorship roster.

  • 3

    Anat Gafter-Gvili's name was also corrected to include a hyphen in the authorship roster.

  • 4

    The funding section was updated to reflect the correct spelling of Benaya Rozen-Zvi's name.

  • 5

    The corrections have been made available online for the referenced article.

Original Source(s)

Correction to: “The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study”

  • August 26, 2025

Related Content

Continuous Glucose Monitoring for Persons With and Without Diabetes

Mild metabolic profile may mask MASLD risk

Five reproducible MASLD subtypes showed distinct genetic profiles and patterns of metabolic comorbidity and disease progression.

Marked Increase in Diabetic Ketoacidosis Rates With Modest Increase in HbA1c Elevation at Diabetes Diagnosis in Swedish Children